Tags

Type your tag names separated by a space and hit enter

Management of Other Gastric and Duodenal Neuroendocrine Tumors.
Surg Oncol Clin N Am. 2020 Apr; 29(2):253-266.SO

Abstract

Gastric and duodenal neuroendocrine tumors (NETs) are increasing in incidence as a result of increased detection and awareness of neuroendocrine tumors as distinct tumor types. The three types of gastric NETs and duodenal NETs have different etiologies and tumor-specific factors, such as grade, location, and hormone-production, and the clinical settings influence management. Options for treatment include removal by local endoscopic resection and surgical resection. Medical therapy is used to treat the inciting condition or as systemic therapy in advanced disease. Although the overall prognosis for most is good, higher grade tumors behave aggressively and have reduced survival.

Authors+Show Affiliations

Section of Endocrine Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903, USA. Electronic address: amanda.laird@cinj.rutgers.edu.Section of Endocrine Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32151359

Citation

Laird, Amanda M., and Steven K. Libutti. "Management of Other Gastric and Duodenal Neuroendocrine Tumors." Surgical Oncology Clinics of North America, vol. 29, no. 2, 2020, pp. 253-266.
Laird AM, Libutti SK. Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020;29(2):253-266.
Laird, A. M., & Libutti, S. K. (2020). Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surgical Oncology Clinics of North America, 29(2), 253-266. https://doi.org/10.1016/j.soc.2019.11.009
Laird AM, Libutti SK. Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020;29(2):253-266. PubMed PMID: 32151359.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Management of Other Gastric and Duodenal Neuroendocrine Tumors. AU - Laird,Amanda M, AU - Libutti,Steven K, PY - 2020/3/11/entrez KW - Carcinoid tumor KW - Duodenal neuroendocrine tumor KW - Gastric neuroendocrine tumor KW - Neuroendocrine KW - Zollinger-Ellison syndrome SP - 253 EP - 266 JF - Surgical oncology clinics of North America JO - Surg. Oncol. Clin. N. Am. VL - 29 IS - 2 N2 - Gastric and duodenal neuroendocrine tumors (NETs) are increasing in incidence as a result of increased detection and awareness of neuroendocrine tumors as distinct tumor types. The three types of gastric NETs and duodenal NETs have different etiologies and tumor-specific factors, such as grade, location, and hormone-production, and the clinical settings influence management. Options for treatment include removal by local endoscopic resection and surgical resection. Medical therapy is used to treat the inciting condition or as systemic therapy in advanced disease. Although the overall prognosis for most is good, higher grade tumors behave aggressively and have reduced survival. SN - 1558-5042 UR - https://www.unboundmedicine.com/medline/citation/32151359/Management_of_Other_Gastric_and_Duodenal_Neuroendocrine_Tumors L2 - https://linkinghub.elsevier.com/retrieve/pii/S1055-3207(19)30105-X DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.